UBS Group set a €123.00 ($143.02) target price on Hannover Re (FRA:HNR1) in a research note published on Tuesday, May 7th, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock.
A number of other brokerages also recently issued reports on HNR1. JPMorgan Chase & Co. set a €114.00 ($132.56) target price on Hannover Re and gave the stock a neutral rating in a research note on Tuesday, May 7th. Royal Bank of Canada set a €130.00 ($151.16) target price on Hannover Re and gave the stock a neutral rating in a research note on Tuesday, May 7th. Independent Research set a €140.00 ($162.79) price target on Hannover Re and gave the stock a neutral rating in a report on Tuesday, May 7th. DZ Bank restated a neutral rating on shares of Hannover Re in a report on Tuesday, May 7th. Finally, Goldman Sachs Group set a €120.00 ($139.53) price target on Hannover Re and gave the stock a sell rating in a report on Tuesday, April 30th. Five equities research analysts have rated the stock with a sell rating and fourteen have given a hold rating to the stock. Hannover Re currently has an average rating of Hold and a consensus target price of €119.15 ($138.55).
HNR1 traded down €1.40 ($1.63) on Tuesday, hitting €133.10 ($154.77). 175,154 shares of the company traded hands. Hannover Re has a 12-month low of €94.75 ($110.17) and a 12-month high of €116.37 ($135.31).
About Hannover Re
Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The Property & Casualty Reinsurance segment offers specialty lines comprising marine, aviation, facultative, credit, surety, and political risks reinsurance products; and treaty, catastrophe XL, and structured reinsurance, as well as insurance-linked securities.
Featured Story: Fundamental Analysis – How It Helps Investors
Receive News & Ratings for Hannover Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hannover Re and related companies with MarketBeat.com's FREE daily email newsletter.